Legal status by country
Is Semax / Selank legal?
Written by Aaron CuhaReviewed Sep 2026
How Semax / Selank is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved; research use only | Not licensed | Not approved | Not approved |
| Note | Neither peptide is FDA-approved. Semax was removed from FDA Category 2 in April 2026 and the Pharmacy Compounding Advisory Committee voted to recommend it for compounding in July 2026; that vote is advisory and no rulemaking has followed. | Neither is licensed. Supply for human use is unlawful. | Not approved; import-restricted. | Not authorized for sale. |
US FDA status: Not approved as a blend or as single agents. Both are registered medicines in Russia; neither has FDA or EMA approval, and no combination product is registered anywhere.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.